NEW YORK ( TheStreet) -- Shares of Immucor ( BLUD) surged in extended trading after the Norcross, Ga.-based provider of blood transfusion reagents and systems topped Wall Street expectations for its second-quarter results.

The company said it earned $21.1 million, or 30 cents a share, in its fiscal second quarter ended Nov. 30, up from a year-ago profit of $19.7 million, or 28 cents a share, and 3 cents ahead of the average estimate of analysts polled by Thomson Reuters. Revenue totaled $81.6 million for the November quarter, also topping Wall Street's consensus estimate of $80 million.

The stock was last quoted at $20.40, up 5.6%, on volume of around 26,000, according to Based on a regular session close at $19.31, the shares are down more than 5% in the past 52 weeks.

Immucor enjoyed an increase in gross margin in the latest quarter to 71.6% from 70.4% in the same period a year earlier but took a measured view of its performance and expressed some caution about the business environment.

"On the whole, our second quarter performance was in line with our expectations," said Gioacchino De Chirico, the president and CEO, in a statement. "We continue to see weakness in the U.S. market due to the macroeconomic environment, which is impacting both our reagent revenue and instrument orders."

For fiscal 2011, Immucor said it expects earnings of $1.08 to $1.18 a share on revenue ranging from $320 million to $332 million. The current analyst view is for a profit of $1.13 a share on revenue of $326.2 million for the year ending in May.

Saba Software

Saba Software ( SABA) was a big decliner in after-hours action after the Redwood Shores, Calif.-based provider of human resources and training applications reported disappointing quarterly results.

The company posted a non-GAAP generally accepted accounting principles profit of $543,000, or 2 cents a share, for the three months ended Nov. 30, well below the average estimate of two analysts polled by Thomson Reuters for earnings of 7 cents a share. Revenue came in at $28.6 million for the quarter, short of the consensus analysts' view of $29.1 million.

The company's increased focus on a "software as a service" business strategy was a contributing factor in the shortfall as more of its customers opted to go the subscription route rather than making outright product purchases.

Saba also gave a weak outlook for the full year, forecasting non-GAAP profit of 10 to 15 cents a share vs. Wall Street's view of 30 cents.

The shares were last quoted at $5.55, down 11.5%, although volume was a light at around 10,000. The stock is up more than 40% in the past year, and its trailing three-month daily average volume is around 81,000.

Borders Group

Borders Group ( BGP) was once again seeing heavy action in extended trading, rising 17% to $1.01 on volume of 1.4 million. The struggling bookseller has been working to refinance a hefty debt load and the Wall Street Journal reported on Thursday it was engaged in talks with restructuring advisors, including Jefferies & Co.

The article said the company is also in discussions with one of its lenders, GE Capital, about entering a new debt agreement to replace its existing senior credit facility. The WSJ also said GE Capital had asked Borders to explore which of its vendors would be willing to delay receiving some payments from the company.

Borders, which counts William Ackman's hedge fund firm Pershing Square Capital Management as its biggest investor with a stake of 41.8% stake, had a debt net of cash balance of $331.1 million as of Sept. 30. Based on a regular session close at 86 cents on Thursday, the stock had lost 26% since reports first surfaced of the company delaying vendor payments.

Liz Claiborne

Shares of Liz Claiborne ( LIZ) lurched lower after the company slashed its profit outlook following a weak December for its Lucky Brand, Juicy Couture and Mexx Europe brands.

The stock was last quoted at $5.69, down 17.5%, on volume of around 950,000. The shares gained more than 15% in 2010, and more than doubled after scraping a 52-week low of $3.90 on July 1.

Liz Claiborne said it now projects the improvement in its adjusted operating income at $40 million to $50 million for the second half of fiscal 2010, which ended in December. Its previous view called for an improvement of $80 million.

-- Written by Michael Baron in New York.

>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.